XTL Biopharmaceuticals Ltd (XTLB) KPIs and segments
Close on Nov 13, 2026Market cap $15.14MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive XTL Biopharmaceuticals's business
XTL Biopharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2024 |
|---|---|---|
Development of pharmaceutical drugs for the treatment of autoimmune diseases($M) | -0.94 | |
Web data collection solutions($M) | -1.23 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2025-04-30.
See a number that looks wrong?